Together, we are stronger.
Gifts in wills
We’re making great strides against cancer. Many of us can remember when people didn’t even want to say the word ‘cancer’ because of its deadly connotation. Thankfully, that’s changed – a lot.
When the Canadian Cancer Society was founded in 1938, only 25% of those diagnosed would survive their cancers. Donors like you have saved millions of lives. Over the decades, we’ve done a lot. Canadians have given generously to invest in cancer research and new, more effective treatments.
Thousands of Canadians have left gifts in their wills to fund the fight against cancer. Those donations have paid off. Today, 65% of people diagnosed with cancer will survive. We’ve come a long– but we still have lots to accomplish.
We’ve made amazing progress in less than one lifetime. But we must continue this fight. No one wants a loved one to face a cancer diagnosis. If we keep believing, and keep giving, we can win this fight for everyone.
Over the years, we’ve learned that every bequest donor is different. Some like to make their gifts in total privacy and anonymity, knowing that the gift will only be revealed once they have died. Others prefer to talk to us beforehand to get information and perhaps some advice on how best to organize their gifts.
Whichever your giving preference, we want you to know that you are more than welcome to reach out to us. Trina Owens is our donor relations officer and is available to talk with you should you so desire. Trina has the experience, expertise and sensitivity to talk with donors about bequest gifts. Please feel free to get in touch with her anytime you wish. She would love to hear from you.
You may call her at 306-790-5819 or email her at email@example.com.
Or you may write to her:
Donor Relations Officer
Canadian Cancer Society, Regina Division Office
1910 McIntyre Street
Regina, SK S4P 2R3
Clinical trial discovery improves quality of life
A clinical trial led by the Society’s NCIC Clinical Trials group found that men with prostate cancer who are treated with intermittent courses of hormone therapy live as long as those receiving continuous therapy.